Rheumatoid Arthritis Clinical Trials

A listing of Rheumatoid Arthritis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
An Open-label Ascending Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Primary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 2-17 years with Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) in order to identify the dose and regimen for adequate treatment of this population Secondary Objective: To describe the pharmacodynamic (PD) profile, the efficacy and the long-term safety of …

DMARD
anti-rheumatic drugs
arthritis
treatment regimen
biologics
  • 0 views
  • 27 Sep, 2021
  • 53 locations
Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

Evaluate long-term safety and tolerability of tofacitinib in patients with JIA, who have previously participated in tofacitinib JIA studies.

DMARD
treatment regimen
arthritis
  • 301 views
  • 27 Sep, 2021
  • 177 locations
Oral Akynzeo vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)

MyRisk: Efficacy and safety evaluation of oral Akynzeo in patients receiving MEC at high risk of developing CINV based on a prediction tool. A multinational and multicenter study. Antiemetic guidelines recommendations are based on the emetogenic potential of the chemotherapy. Chemotherapy (CT) agents are divided in Highly, Moderately, Low and …

  • 3 views
  • 25 Sep, 2021
  • 3 locations
Usefulness of Non TNF Usage in RA Patients

The aim of this study is to examine the efficacy and adverse events in the following 3 groups in rheumatoid arthritis patients: Sarilumab treatment for 12 months

abatacept
tumor necrosis factor
  • 0 views
  • 26 Sep, 2021
  • 1 location
Evaluation of the Condition of Rheumatoid Arthritis After Treatment

To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients

  • 0 views
  • 26 Sep, 2021
  • 1 location
Examination of Efficacy and Safety of Baricitinib in RA Patients

The aim of this study is to examine the efficacy and adverse events in the following 3 groups in rheumatoid arthritis patients: Baricitinib treatment for 12 months

baricitinib
tofacitinib
  • 4 views
  • 26 Sep, 2021
  • 1 location
Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

The RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderate to severe rheumatoid arthritis who have had

DMARD
antirheumatics
  • 0 views
  • 17 Sep, 2021
  • 24 locations
Radium Ra 223 Dichloride Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

This phase 2 trial studies radium Ra 223 dichloride, hormone therapy and stereotactic body radiation in treating patients with prostate cancer that has spread to other places in the body. Radium

positron emission tomography
neutrophil count
prostatectomy
bicalutamide
cancer
  • 1 views
  • 22 Sep, 2021
  • 1 location
Anterior Advantage With KINCISE

This is a post-market prospective, 1:1 randomized, multicenter non-inferiority study to compare the femoral broaching time for THA with the Anterior Advantage approach with KINCISE vs. without KINCISE. Follow-up will continue through 24 weeks post-op.

joint reconstruction
hip replacement
hip arthroplasty
  • 3 views
  • 15 Sep, 2021
  • 8 locations
Olaparib and Radium Ra 223 Dichloride in Treating Men With Metastatic Castration-Resistant Prostate Cancer That Has Spread to the Bone

This phase I/II trial studies the best dose and side effects of olaparib and how well it works with radium Ra 223 dichloride in treating patients with castration-resistant prostate cancer that

progressive disease
bone disease
tumor cells
apalutamide
biomarker analysis
  • 92 views
  • 22 Sep, 2021
  • 15 locations